Does heterogeneity decrease the quality rating when using the JBI Critical Appraisal Checklist for Systematic Reviews?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Heterogeneity Decrease Quality Rating in JBI Critical Appraisal?

No, heterogeneity itself does not directly decrease the quality rating when using the JBI Critical Appraisal Checklist for Systematic Reviews—the JBI checklist assesses methodological quality and risk of bias in the review process, not the statistical heterogeneity of included studies.

Understanding the Distinction

The JBI Critical Appraisal Checklist for Systematic Reviews evaluates the methodological rigor of how a systematic review was conducted, not the characteristics of the data being synthesized 1. The checklist contains 11 questions assessing specific domains to determine potential risk of bias, with responses of "yes," "no," "unclear," or "not applicable" 1. Quality ratings are calculated by dividing the number of "yes" responses by total scored items, with cutoffs of ≥70% for low risk, 50-69% for moderate risk, and <50% for high risk of bias 1.

Where Heterogeneity Actually Matters

Heterogeneity is addressed separately in the GRADE assessment of certainty of evidence, not in the JBI critical appraisal of review quality 2. The GRADE approach evaluates five domains: overall study risk of bias, inconsistency (which includes heterogeneity), indirectness, imprecision, and publication bias 2.

Key distinction:

  • JBI checklist = assesses whether reviewers conducted their systematic review properly
  • GRADE/certainty assessment = evaluates the strength and consistency of the evidence itself

How Heterogeneity Should Be Handled

When substantial statistical heterogeneity is present (I² >50%, Chi² P<0.1, or Tau² >0), best practice dictates 2:

  • Meta-analysis should not be performed
  • Results should be reported separately
  • Random effects models should be used if pooling is attempted with moderate heterogeneity
  • Fixed effect models only when minimal heterogeneity exists

The presence of heterogeneity and how reviewers respond to it can affect JBI quality ratings indirectly—if reviewers fail to appropriately assess or address heterogeneity in their methods, this reflects poor methodological quality 3, 4.

Common Pitfalls

Avoid conflating these concepts:

  • High heterogeneity in study results ≠ poor quality systematic review
  • A well-conducted review can identify and appropriately handle heterogeneous data
  • Conversely, a poorly conducted review might inappropriately pool heterogeneous studies, which would lower the JBI quality rating because it reflects methodological failure 5

The I² statistic quantifies variation across studies beyond chance, with values <25% considered low 3, 4. However, reviewers should exercise caution when few studies are available, as I² has large uncertainty in these situations 3, 4.

Bottom line: Heterogeneity affects the certainty of evidence and appropriateness of meta-analysis, but the JBI checklist evaluates whether the systematic review authors properly identified, reported, and handled that heterogeneity—not the heterogeneity itself 2, 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.